Statement on the Use of Hydroxychloroquine and Azithromycin for COVID-19 Prophylaxis 

As front-line health-care professionals, you may be aware that there has been significant mention in both social media and on the internet on the use of certain anti-malarial, antibiotic and antiviral therapies in the treatment of COVID-19 patients. Notwithstanding the widespread hope that a cure or treatment for COVID-19 symptoms is found quickly, Ontarians have an expectation and confidence that their health team members – physicians, nurse practitioners and pharmacists – are and will continue to work together to ensure that prescribing and dispensing of medications for the treatment of this deadly virus is evidence-based and with ultimate safety in mind.

Please read the statement.

Follow us
   

You have received this email because you indicated you want to receive information about .

If you no longer wish to receive emails about , please update your email preferences below:

• I no longer wish to receive emails about
• I no longer wish to receive any emails from RNAO
• Log in to update your email preferences

Registered Nurses’ Association of Ontario (RNAO)
Copyright
All rights reserved